Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chlamydia infections
3.2.1.2 Advancements in diagnostic technologies
3.2.1.3 Growing adoption of home testing kits
3.2.1.4 Increase in government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of awareness in low and middle-income countries
3.2.2.2 Social stigma and confidentiality concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Gap analysis
3.10 Product pipeline analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Nucleic acid amplification test (NAAT)
5.3 Serology test
5.4 Direct fluorescent antibody test
5.5 Culture test
5.6 Other test types
Chapter 6 Market Estimates and Forecast, By Type of Infections, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Genital chlamydia infection
6.3 Rectal chlamydia infection
6.4 Ocular chlamydia infection
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Specialty clinics
7.4 Diagnostic centres
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Abbott
9.2 BD
9.3 Bio-Rad Laboratories, Inc.
9.4 DiaSorin S.p.A.
9.5 F. Hoffmann-La Roche Ltd
9.6 Hologic, Inc.
9.7 QuidelOrtho Corporation.
9.8 Siemens Healthineers
9.9 Thermo Fisher Scientific Inc.
9.10 Trinity Biotech Plc.
